- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (74)
7 result(s) found for: Chlorpheniramine.
Displaying page 1 of 1.
| EudraCT Number: 2014-000537-24 | Sponsor Protocol Number: IIS-HEPA-TEST | Start Date*: 2014-07-16 |
| Sponsor Name:INSTITUTO DE INVESTIGACION SANITARIA LA FE | ||
| Full Title: Pilot clinical trial phase I / IIa to determine condition, low dose and effectiveness of liver function tests (Hepatotest) | ||
| Medical condition: Hepatic Function. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-001974-11 | Sponsor Protocol Number: HEPATOTEST | Start Date*: 2013-08-29 |
| Sponsor Name:INSTITUTO DE INVESTIGACION SANITARIA LA FE | ||
| Full Title: PILOT TRIAL FOR THE EVALUATION OF HEPATOTEST IN PREOPERATIVE ASSESSMENT IN LIVER FUNCTION. | ||
| Medical condition: Patients with liver metastases (mainly colorectal cancer) who will be undergoing major hepatic resection (3 or more liver segments) which have been treated with neoadjuvant chemotherapy. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-002785-39 | Sponsor Protocol Number: BRN-C-2013-04 | Start Date*: Information not available in EudraCT | |||||||||||
| Sponsor Name:Laboratoires BOIRON | |||||||||||||
| Full Title: | |||||||||||||
| Medical condition: | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2005-005207-42 | Sponsor Protocol Number: 2005079 | Start Date*: 2005-12-29 | |||||||||||
| Sponsor Name:Procter & Gamble Technical Centres Limited | |||||||||||||
| Full Title: A study to assess the efficacy of a combination of natural plant extracts in natural colds. | |||||||||||||
| Medical condition: Common Cold (nasopharyngitis), Upper Respiratory Tract Infection | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2013-004524-11 | Sponsor Protocol Number: 2013105 | Start Date*: 2013-12-16 | ||||||||||||||||
| Sponsor Name:Proctor and Gamble Technical Centres Ltd | ||||||||||||||||||
| Full Title: A 2-arm, randomised, single - (investigator) blind, controlled, parallel design study in common cold sufferers experiencing cough and nasal congestion to assess the effects of VicksĀ® VapoRubĀ® (VVR)... | ||||||||||||||||||
| Medical condition: Sleep disruption due to cough and nasal congestion during a cold. | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: GB (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2022-002579-12 | Sponsor Protocol Number: CLL2222 | Start Date*: 2023-04-04 | |||||||||||
| Sponsor Name:FONDAZIONE GIMEMA (GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL' ADULTO) FRANCO MANDELLI ONLUS | |||||||||||||
| Full Title: Front-Line Venetoclax and Obinutuzumab combination followed by Venetoclax or Venetoclax and Zanubrutinib combination in patients with residual disease: a minimal residual disease (MRD) tailored tre... | |||||||||||||
| Medical condition: Chronic Lymphocytic Leukemia | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2022-003559-32 | Sponsor Protocol Number: CPO19001 | Start Date*: 2023-03-16 | ||||||||||||||||
| Sponsor Name:PharOS Pharmaceutical Oriented Services Single Member Ltd. | ||||||||||||||||||
| Full Title: A Phase III Prospective, Randomized, Multicenter, Double-Blind, Placebo-controlled clinical study to evaluate the efficacy and safety of fixed dose combination (FDC) product Ibuprofen/Paracetamol/P... | ||||||||||||||||||
| Medical condition: Temporary relief of cold and flu symptoms, i.e. mild to moderate pain, sore throat, fever and nasal congestion | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: BG (Completed) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.